Role of vitamin D/VDR nuclear translocation in down-regulation of NF- κB/NLRP3/caspase-1 axis in lupus nephritis
CONCLUSION: LN pathogenesis decreased after paricalcitol treatment. We observed a marked improvement in renal pathology and a time-dependent decrease urine protein and serum anti-dsDNA antibody levels. In 16-week-old MRL/lpr LN mice, the upregulated expression of NLRP3/caspase-1/IL-1β/IL-18 axis was significantly downregulated after paricalcitol treatment. Paricalcitol can reverse the apoptosis induced by anti-dsDNA antibody via the NF-κB/NLRP3/caspase-1/IL-1β/IL-18 axis in mRTECs. Furthermore, paricalcitol suppressed NF-κB nuclear translocation by competitively binding to importin-4. In summary, the VDR agonist can alleviate LN by modulating the NF-κB/NLRP3/caspase-1/IL-1β/IL-18 axis and suppressing the NF-κB nuclear translocation.PMID:34536747 | DOI:10.1016/j.intimp.2021.108131
Source: International Immunopharmacology - Category: Allergy & Immunology Authors: Jing Huang Qi An Bo-Miao Ju Jing Zhang Ping Fan Lan He Lei Wang Source Type: research
More News: Allergy & Immunology | Lupus | Nephritis | Pathology | Proteinuria | Study | Translocation | Urology & Nephrology | Vitamin D | Vitamins